Johnson and Johnson vaccine produced strong immune response, early results say
5 years ago 1 min read
Early results from a Phase 1/2a clinical trial shows it was well tolerated and even one dose appeared to produce a strong immune response in almost all of the 800 participants.
More Stories
Record Korean Cases; Trader’s Guide to Rollout: Virus Update
California Hits Record; Trader’s Guide to Rollout: Virus Update
AstraZeneca to Buy Alexion for $39 Billion in Rare-Disease Push